Baxter (BAX) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street mostly rises as Fed holds key rate steady, deferring next likely hike to December
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- Oracle sets $225 billion revenue target for FY30 at investor day
- S&P Global explores potential separation of Capital IQ business
- Rivian shares slip ahead of Thursday earnings release
- SpaceX stock drops amid spaceport lawsuit, debt concerns
- Moderna stock rises on latest cancer vaccine data publication
Leerink Partners Downgrades Baxter International (BAX) to Market Perform
July 30, 2015 7:43 AM EDTLeerink Partners downgraded Baxter International (NYSE: BAX) from Outperform to Market Perform with a price target of $40.00 (from $82.00).
Analyst Danielle Antalffy commented, "We are downgrading BAX shares to MP with a $40 12-month price target. Despite delivering solid 2Q15 results, post-split new BAX valuation appears lofty to us, already seeming to factor in potential upside in both sales... More
Baxter (BAX) Declares $0.115 Quarterly Dividend; 1.2% Yield
July 29, 2015 4:18 PM EDTBaxter (NYSE: BAX) declared a quarterly dividend at a new rate of $0.115 per share, or $0.46 annualized, following its successful spin-off of its biopharmaceuticals business, Baxalta Incorporated.
The dividend will be payable on October 1, 2015, to stockholders of record on September 4, 2015, with an ex-dividend... More



